Prime Medicine (PRME) Cash from Financing Activities (2021 - 2026)
Prime Medicine (PRME) posted Cash from Financing Activities of $361,000 for Q2 2026, up 83.2% from $197,000 a year earlier but down 8.1% from the prior quarter.
Powered by 
Analysis
Prime Medicine (PRME) Cash from Financing Activities (2021 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Cash from Financing Activities at Prime Medicine was $146.07 million, up 226.7% year-over-year; for FY2025, it came in at $151.51 million, down 22.6% from FY2024.
- Annual Cash from Financing Activities shows a five-year compound annual growth rate of 34.1% (FY2020 to FY2025).
- In prior years, Prime Medicine's Cash from Financing Activities was $195.88 million in FY2024, $655,000 in FY2023 (-99.6%), $181.49 million in FY2022 (-32.6%) and $269.28 million in FY2021 (+670.8%).
- Quarterly Cash from Financing Activities has run from a low of -$1.27 million in Q1 2022 to a high of $184.07 million in Q4 2022 over five years.
- On a year-over-year basis, Cash from Financing Activities increased in three of the last six quarters, with growth averaging 88.8%.
- The strongest year-over-year quarter for Cash from Financing Activities in the past five years was Q2 2025, with growth of 462.9%; the weakest was Q4 2023, with a decline of 99.9%.
- According to Business Quant data, Cash from Financing Activities for the three prior quarters was $393,000 (Q1 2026), $562,000 (Q4 2025) and $144.75 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | -8.78 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | -5.05 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 1.76 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | -2.02 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | -47.00 Mn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | -1.48 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 2.34 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | -3.66 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | -426.70 Mn |
| 10 | Prime Medicine | 553.06 Mn | 553.06 Mn | - | 361,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 361,000.00 |
| Mar 31, 2026 | 393,000.00 |
| Dec 31, 2025 | 562,000.00 |
| Sep 30, 2025 | 144.75 Mn |
| Jun 30, 2025 | 197,000.00 |
| Mar 31, 2025 | 6.00 Mn |
| Dec 31, 2024 | 1,000.00 |
| Sep 30, 2024 | 38.51 Mn |
| Jun 30, 2024 | 35,000.00 |
| Mar 31, 2024 | 157.33 Mn |
| Dec 31, 2023 | 194,000.00 |
| Sep 30, 2023 | 318,000.00 |
| Jun 30, 2023 | 75,000.00 |
| Mar 31, 2023 | 68,000.00 |
| Dec 31, 2022 | 184.07 Mn |
| Sep 30, 2022 | -683,000.00 |
| Jun 30, 2022 | -624,000.00 |
| Mar 31, 2022 | -1.27 Mn |
| Dec 31, 2021 | -1.09 Mn |
API Access
Prime Medicine Cash from Financing Activities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=PRME&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-from-financing-activities", "ticker": "PRME", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=PRME&period=max&api_key=YOUR_API_KEY");
const data = await res.json();